Cranberry Juice and Warfarin: When Bad Publicity Trumps Science


      Based on anecdotal reports, the question of whether cranberry juice interacts with warfarin has been raised. This article discusses the potential mechanism, and systematically reviews case reports as well as clinical trials examining the possible interaction. We systematically searched MEDLINE via PubMed, and the Cochrane Library database. Fifteen case reports were summarized, including the initial unpublished brief reports to the Committee on Safety of Medicines and the subsequent 6 published case reports. Seven clinical trials were analyzed, including 3 studies using warfarin and 4 surrogate drugs. Only 2 cases had a validation scale suggesting a “probable” interaction, but even in these patients there were many reasons to question the validity of a relevant drug interaction. Randomized clinical trials and surrogate markers found no evidence to support the interaction between cranberry juice and warfarin. Because the moderate consumption of cranberry juice does not affect anticoagulation, we encourage the reexamination of initial warnings based on scientific evidence. We conclude that the initial precautionary warnings by administrating bodies are limited to anecdotal case reports and represent misleading conclusions.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Committee on Safety of Medicines, Medicines and Healthcare Products Regulatory Agency
        Possible interaction between warfarin and cranberry juice.
        Curr Probl Pharmacovigilance. 2003; 29: 8
        • Medicines and Healthcare Products Regulatory Agency/Committee on Safety of Medicines
        Interaction between warfarin and cranberry juice: new advice.
        Curr Probl Pharmacovigilance. 2003; 30: 10
        • Yamazaki H.
        • Shimada T.
        Human liver cytochrome P450 enzyme involved in the 7-hyroxylation of R- and S-warfarin enantiomers.
        Biochem Pharmacol. 1997; 54: 1195-1203
        • He M.
        • Kunze K.L.
        • Traeger W.F.
        Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
        Drug Metab Dispos. 1995; 23: 659-663
        • Greenblatt D.
        • Von Moltke L.
        Interaction of warfarin with drugs, natural substances, and foods.
        J Clin Pharmacol. 2005; 45: 127-132
        • Suvarna R.
        • Pirmohamed M.
        • Henderson L.
        Possible interaction between warfarin and cranberry juice.
        BMJ. 2003; 327: 1454
        • Grant P.
        Warfarin and cranberry juice: an interaction?.
        J Heart Valve Dis. 2004; 13: 25-26
        • Rindone J.
        • Murphy T.
        Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding.
        Am J Ther. 2006; 13: 283-284
        • Mergenhagen K.A.
        • Sherman O.
        Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin.
        Am J Health Syst Pharm. 2008; 65: 2113-2116
        • Welch J.M.
        • Forster K.
        Probable elevation in international normalized ratio from cranberry juice.
        J Pharm Technol. 2007; 23: 104-107
        • Paeng C.H.
        • Sprague M.
        • Jackevicius C.A.
        Interaction between warfarin and cranberry juice.
        Clin Ther. 2007; 29: 1730-1735
        • Li Z.
        • Seeram N.
        • Carpenter C.
        • et al.
        Cranberry does not affect prothrombin time in male subjects on warfarin.
        J Am Diet Assoc. 2006; 106: 2057-2061
        • Ansell J.
        • McDonough M.
        • Harmatz J.
        • Greenblatt D.
        A randomized, double-blind trial of the interaction between cranberry juice and warfarin.
        J Thromb Thrombolysis. 2008; 25: 112
        • Mohammed Abdul M.I.
        • Jiang X.
        • Williams K.M.
        • et al.
        Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.
        Br J Pharmacol. 2008; 154: 1691-1700
        • Greenblatt D.
        • Von Moltke L.
        • Perloff E.
        • et al.
        Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies.
        Clin Pharmacol Ther. 2006; 79;: 125-133
        • Grenier J.
        • Fradette C.
        • Morelli G.
        • et al.
        Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans.
        Clin Pharmacol Ther. 2006; 79: 255-262
        • Lilja J.
        • Backman J.
        • Neuvonen P.
        Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam-probes of CYP2C9, CYP1A2, and CYP3A4.
        Clin Pharmacol Ther. 2007; 81: 833-839
        • Ngo N.
        • Yan Z.
        • Graf T.N.
        • et al.
        Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans.
        Drug Metab Dispos. 2009; 37: 514-522
        • Lee C.R.
        • Goldstein J.A.
        • Pieper J.A.
        Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.
        Pharmacogenetics. 2002; 12: 251-263
        • Kaminsky L.S.
        • Zhang Z.Y.
        Human P450 metabolism of warfarin.
        Pharmacol Ther. 1997; 73: 67-74
        • Holbrook A.M.
        • Pereira J.A.
        • Labiris R.
        • et al.
        Systematic overview of warfarin and its drug and food interactions.
        Arch Intern Med. 2005; 165: 1095-1106
        • Naranjo C.A.
        • Busto U.
        • Sellers E.M.
        • et al.
        A method for estimating the probability of adverse drug reactions.
        Clin Pharm Ther. 1981; 30: 239-245
        • Horn J.R.
        • Hansten P.D.
        • Chan L.N.
        Proposal for a new tool to evaluate drug interaction cases.
        Ann Pharmacother. 2007; 41: 674-680
        • Chen H.
        • Zuo Y.
        • Deng Y.
        Separation and determination of flavonoids and other phenolic compounds in cranberry juice by high-performance liquid chromatography.
        J Chromatogr A. 2001; 913: 387-395
        • Lynch D.
        Cranberry for prevention of urinary tract infections.
        Am Fam Physician. 2004; 70: 2175-2177
        • Pham D.Q.
        • Pham A.Q.
        Interaction potential between cranberry juice and warfarin.
        Am J Health Syst Pharm. 2007; 64: 490-494
        • Aston J.L.
        • Lodolce A.E.
        • Shapiro N.L.
        Interaction between warfarin and cranberry juice.
        Pharmacotherapy. 2006; 26: 1314-1319